Addex Therapeutics Future Growth
Future criteria checks 3/6
Addex Therapeutics is forecast to grow earnings and revenue by 119% and 127% per annum respectively while EPS is expected to grow by 108.6% per annum.
Key information
119.0%
Earnings growth rate
108.6%
EPS growth rate
| Biotechs earnings growth | 31.5% |
| Revenue growth rate | 127.0% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 29 Apr 2024 |
Recent future growth updates
Recent updates
Here's Why Addex Therapeutics (VTX:ADXN) Must Use Its Cash Wisely
Mar 03
Here's Why Addex Therapeutics (VTX:ADXN) Must Use Its Cash Wisely
May 11Is Addex Therapeutics (VTX:ADXN) In A Good Position To Invest In Growth?
Nov 23Increases to CEO Compensation Might Be Put On Hold For Now at Addex Therapeutics Ltd (VTX:ADXN)
Jun 10Is Addex Therapeutics (VTX:ADXN) In A Good Position To Invest In Growth?
Mar 07What Type Of Returns Would Addex Therapeutics'(VTX:ADXN) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Jan 12Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 20 | 14 | 14 | 14 | 1 |
| 12/31/2024 | N/A | -6 | -6 | -6 | 1 |
| 12/31/2023 | 2 | -11 | -8 | -8 | N/A |
| 9/30/2023 | 2 | -11 | -10 | -10 | N/A |
| 6/30/2023 | 2 | -13 | -11 | -11 | N/A |
| 3/31/2023 | 2 | -17 | -14 | -14 | N/A |
| 12/31/2022 | 1 | -21 | -16 | -16 | N/A |
| 9/30/2022 | 1 | -22 | -16 | -16 | N/A |
| 6/30/2022 | 2 | -21 | -16 | -16 | N/A |
| 3/31/2022 | 2 | -19 | -17 | -17 | N/A |
| 12/31/2021 | 3 | -15 | -15 | -15 | N/A |
| 9/30/2021 | 5 | -13 | -11 | -11 | N/A |
| 6/30/2021 | 4 | -13 | -11 | -11 | N/A |
| 3/31/2021 | 4 | -11 | -11 | -11 | N/A |
| 12/31/2020 | 4 | -13 | -12 | -12 | N/A |
| 9/30/2020 | 3 | -14 | -13 | -13 | N/A |
| 6/30/2020 | 3 | -15 | -15 | -15 | N/A |
| 3/31/2020 | 3 | -16 | -11 | -11 | N/A |
| 12/31/2019 | 3 | -15 | -10 | -9 | N/A |
| 9/30/2019 | 2 | -13 | -10 | -10 | N/A |
| 6/30/2019 | 3 | -12 | -6 | -6 | N/A |
| 3/31/2019 | 5 | -6 | -3 | -3 | N/A |
| 12/31/2018 | 7 | -2 | 2 | 2 | N/A |
| 9/30/2018 | 6 | 0 | 2 | 2 | N/A |
| 6/30/2018 | 6 | 1 | 2 | 2 | N/A |
| 3/31/2018 | 3 | -1 | 0 | 0 | N/A |
| 12/31/2017 | 0 | -3 | -2 | -2 | N/A |
| 9/30/2017 | 0 | -3 | N/A | -2 | N/A |
| 6/30/2017 | 0 | -3 | N/A | -2 | N/A |
| 3/31/2017 | 0 | -3 | N/A | -2 | N/A |
| 12/31/2016 | 0 | -3 | N/A | -3 | N/A |
| 9/30/2016 | 1 | -3 | N/A | -3 | N/A |
| 6/30/2016 | 1 | -3 | N/A | -3 | N/A |
| 3/31/2016 | 1 | -4 | N/A | -3 | N/A |
| 12/31/2015 | 1 | -4 | N/A | -3 | N/A |
| 9/30/2015 | 1 | -4 | N/A | -2 | N/A |
| 6/30/2015 | 0 | -4 | N/A | -2 | N/A |
| 3/31/2015 | 0 | -3 | N/A | -2 | N/A |
| 12/31/2014 | 0 | -2 | N/A | -2 | N/A |
| 9/30/2014 | 0 | -2 | N/A | -4 | N/A |
| 6/30/2014 | N/A | -1 | N/A | -6 | N/A |
| 3/31/2014 | 0 | -8 | N/A | -11 | N/A |
| 12/31/2013 | 0 | -14 | N/A | -16 | N/A |
| 9/30/2013 | 0 | -20 | N/A | -20 | N/A |
| 6/30/2013 | 0 | -26 | N/A | -24 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ADXN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.2%).
Earnings vs Market: ADXN is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ADXN is expected to become profitable in the next 3 years.
Revenue vs Market: ADXN is forecast to have no revenue next year.
High Growth Revenue: ADXN is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ADXN's Return on Equity is forecast to be high in 3 years time